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Abstract 
Background: Streptococcus suis serotype 2 is an important porcine pathogen and emerging zoonotic agent respon‑
sible for meningitis, of which different sequence types predominate worldwide. Though bacterial meningitis is 
defined as an exacerbated inflammation of the meninges, the underlying astrocytes of the glia limitans superficialis 
may also be implicated. However, the interactions between this pathogen and human meningeal cells or astrocytes 
remain unknown. Furthermore, the roles of well‑described virulence factors (capsular polysaccharide, suilysin and cell 
wall modifications) in these interactions have yet to be studied. Consequently, the interactions between S. suis sero‑
type 2 and human meningeal cells or astrocytes were evaluated for the first time in order to better understand their 
involvement during meningitis in humans.
Results: Streptococcus suis serotype 2 adhered to human meningeal cells and astrocytes; invasion of meningeal cells 
was rare however, whereas invasion of astrocytes was generally more frequent. Regardless of the interaction or cell 
type, differences were not observed between sequence types. Though the capsular polysaccharide modulated the 
adhesion to and invasion of meningeal cells and astrocytes, the suilysin and cell wall modifications only influenced 
astrocyte invasion. Surprising, S. suis serotype 2 induced little or no inflammatory response from both cell types, but 
this absence of inflammatory response was probably not due to S. suis‑induced cell death.
Conclusions: Though S. suis serotype 2 interacted with human meningeal cells and astrocytes, there was no correla‑
tion between sequence type and interaction. Consequently, the adhesion to and invasion of human meningeal cells 
and astrocytes are strain‑specific characteristics. As such, the meningeal cells of the leptomeninges and the astrocytes 
of the glia limitans superficialis may not be directly implicated in the inflammatory response observed during meningi‑
tis in humans.
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Background
Streptococcus suis is an important porcine bacterial 
pathogen and emerging zoonotic agent responsible for 
sepsis and meningitis [1]. Of the thirty-five described 
serotypes, based on the presence of the capsular poly-
saccharide (CPS) or its respective genes, serotype 2 is 
regarded as the most widespread and virulent, responsi-
ble for the majority of porcine and human cases of infec-
tion worldwide [2]. In fact, 97  % of the approximately 
1300 serotyped S. suis cases of infection in humans were 
caused by the serotype 2, of which nearly 70 % presented 
clinical signs of meningitis [2]. Furthermore, this patho-
gen is the first cause of adult bacterial meningitis in 
Vietnam, the second most common in Thailand, and the 
third most frequent cause of community-acquired bacte-
rial meningitis in Hong Kong [2]. The use of multilocus 
sequence typing has identified four predominate sero-
type 2 sequence types (ST): the ST1 in Eurasia, the ST7, 
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responsible for the human outbreaks of 1998 and 2005, 
in China, and the ST25 and ST28 in North America [2]. 
In addition, porcine and human cases of infection have 
been attributed to ST25 and ST28 strains in Thailand and 
Japan, though less frequently [2]. Moreover, differential 
interactions have been observed between STs using vari-
ous cell types from different species [3, 4].
Of the multitude of S. suis serotype 2 virulence fac-
tors described [1], the CPS, suilysin (SLY) and cell wall 
modifications have been well-characterized. The CPS is 
a critical factor implicated in a multitude of functions, 
most importantly in the resistance to phagocytosis [5, 6]. 
Meanwhile, the SLY is a hemolysin responsible for caus-
ing cell cytotoxicity [7]. Finally, cell wall modifications, 
such as the D-alanylation of the lipoteichoic acid (LTA) 
and N-deacetylation of the peptidoglycan (PGN), are 
known to interfere with the immune response; the D-ala-
nylation of the LTA was also shown to modulate adhesion 
to and invasion of endothelial cells [6, 8, 9].
The interactions between S. suis serotype 2 and cer-
tain cells of the central nervous system (CNS) have been 
studied, including porcine brain microvascular endothe-
lial cells (pBMEC) and porcine choroid plexus epithelial 
cells (CPEC), as well as murine microglia and astrocytes 
[4, 10–12]. However, few studies have used human cells: 
only the interactions with human BMEC (hBMEC) and 
choroid plexus papilloma cells have been reported [13, 
14], while those with meningeal cells and other cells of 
the human CNS remain unknown. The meninges are 
composed of the dura mater and leptomeninges: the 
latter are formed of the pia mater and arachnoid mater 
together with the trabeculae that traverse the cerebro-
spinal fluid (CSF)-filled subarachnoid space (SAS) [15]. 
The pia mater overlies the glia limitans superficialis, a 
layer of compact astrocytes that surrounds the brain and 
forms a barrier [16]. While astrocytes play a crucial role 
in cerebral homeostasis, they also participate in inflam-
mation, though this role has only begun to be studied [17, 
18]. Consequently, astrocytes possess a multitude of pat-
tern recognition receptors involved in the innate immune 
response, including Toll-like receptors (TLRs) and 
nucleotide-binding oligomerization domain (NOD)-like 
receptors (NLRs) [18]. As such, these cells are a source of 
certain inflammatory mediators [18].
Penetration of the CPEC that form the blood-CSF bar-
rier by S. suis, from the underlying blood vessels, is a 
proposed portal of entry into the CNS [14, 19]. Conse-
quently, the leptomeninges and underlying astrocytes of 
the glia limitans are possibly implicated in both porcine 
and human S. suis infections, which are characterized by 
meningitis (inflammation of the leptomeninges) often 
accompanied by inflammation of the surrounding CNS 
tissues, such as the glia limitans [20]. The interactions 
of different important meningitis-causing human bacte-
rial pathogens with these cells have already been studied 
[21–24].
In this study, the interactions between different S. suis 
serotype 2 strains and human meningeal cells or astro-
cytes, including certain well-characterized virulence fac-
tors, were evaluated for the first time in order to better 
understand the implication of the meninges and underly-
ing CNS tissue during meningitis in humans.
Results and discussion
Streptococcus suis serotype 2 adheres to but rarely 
invades human meningeal cells and these interactions are 
modulated by the CPS
Though a high blood bacterial load is often regarded 
as crucial for the development of meningitis by extra-
cellular bacterial pathogens (eg. Escherichia coli) [25], 
this remains unknown for S. suis. Nonetheless, bacteria 
must breach one of the physiological barriers that sep-
arate the brain: the blood-CSF barrier is the preferred 
site of entry into the CNS for most meningitis-causing 
human bacterial pathogens, which subsequently reach 
the CSF and the meningeal cells with which they may 
interact [19]. Bacterial adhesion to the cell surface is 
considered a critical host-pathogen interaction. Con-
sequently, the adhesion of the S. suis strains, belonging 
to different STs, to human meningeal cells was meas-
ured. Since primary human leptomeningeal cells can-
not be reliably cultured, previously established human 
leptomeningioma cell cultures were used [26]. These 
cells present the same cytological and morphologi-
cal structures as their primary counterparts [24] and 
have been used with various meningitis-causing human 
bacterial pathogens [21, 23]. The ST1, ST7, ST25, and 
ST28 strains all adhered to meningeal cells, with associ-
ated bacteria ranging between 5 ×  104 colony forming 
units (CFU) and 1 × 107 CFU, equivalent to 1 and 2500 
bacteria/cell, respectively (Fig.  1A). Though significant 
differences were not observed between STs, there were 
differences between strains: P1/7 and 89–1591 adhered 
significantly less and more than the other strains 
(p  <  0.01), respectively. These differences suggest the 
partial implication of strain-specific factors [1], which 
remain largely unknown since nearly all virulence stud-
ies have been conducted using ST1, and more recently, 
ST7 strains [1]. Consequently, very little is known 
regarding ST25 and ST28-specific virulence factors, 
including those implicated in adhesion. The adhesion 
levels of S. suis are similar to those reported for group 
B Streptococcus (GBS) serotypes III and V, yet S. suis 
adhered more strongly than other important encapsu-
lated human bacterial pathogens, such as Streptococcus 
pneumoniae serotype 2, Haemophilus influenzae type 
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b and E. coli K1, but less so than Neisseria meningitidis 
serogroup B, when similar initial concentrations were 
used [21, 23]. This adhesion capacity of S. suis sero-
type 2 had also been observed when porcine tracheal 
epithelial cells, human lung epithelial cells, hBMEC or 
pBMEC were infected with ST1 strains [11, 13, 27, 28]. 
Importantly, this is the first time that the interactions 
between S. suis serotype 2 ST25 or ST28 strains and 
CNS cells, other than the BMECs, have been studied, 
regardless of the species. Unlike with human and por-
cine intestinal epithelial cells [29], no differences were 
observed between adhesion of human or porcine S. suis 
serotype 2 strains to human meningeal cells.
Since S. suis adhered to meningeal cells, its capacity 
to subsequently invade the cells was evaluated. Bacterial 
invasion ranged between 2 ×  103 and 7 ×  103 CFU for 
the different strains, equivalent to 0.05 and 0.2 intracel-
lular bacterium/cell, respectively, with the exception of 
the ST7 strain, for which 8 ×  104 CFU were recovered, 
equivalent to 2 intracellular bacteria/cell (Fig. 1B). Unfor-
tunately, the definition of bacterial invasion remains 
controversial and subjective, with no criterion allow-
ing to determine with certainty if a bacterial strain is 
invasive [30]. Though the number of internalized bac-
teria required for S. suis serotype 2 to induce meningi-
tis remains unknown, it was previously suggested that 
Fig. 1 Interactions of S. suis serotype 2 with human meningeal cells. Bacterial adhesion (A) and invasion (B) of human meningeal cells by the S. suis 
strains belonging to different sequence types (STs), and adhesion (C) and invasion (D) of human meningeal cells by the mutant strains. Results are 
expressed as log10 mean ± SEM CFU obtained from three independent experiments. Dotted lines indicate a ratio of 1 intracellular bacterium/cell. 
The use of different letters (a, b or c) indicates a significant difference between groups (p < 0.01); ***(p < 0.001)
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the survival of a single intracellular H. influenzae may 
result in meningitis [31]. Consequently, biologically rel-
evant invasion was defined as 1 intracellular bacterium/
cell in this study. As such, only the ST7 was capable, in 
theory, of meningeal cell invasion: this capacity could be 
the result of unique factors, since important differences 
have been observed in the genome of this strain when 
compared to ST1 and ST25 strains [32]. The general ina-
bility of S. suis to invade meningeal cells is a character-
istic shared with GBS, S. pneumoniae and H. influenzae 
[21, 23]. By contrast, N. meningitidis and E. coli invaded 
meningeal cells [23]. It was previously demonstrated that 
though S. suis serotype 2 invaded porcine tracheal epi-
thelial cells, it did not invade human lung epithelial cells 
or hBMEC; invasion of pBMEC remains controversial 
however [11, 13, 27, 28, 30]. Breaching of the meningeal 
cell barrier via the paracellular route cannot be discarded 
however, since this route is difficult to evaluate in the 
absence of transwell inserts and measuring of the tran-
sepithelial electrical resistance. Although described for 
intestinal epithelial cells [29], this route of entry has not 
yet been described for S. suis in the CNS, where bacte-
ria were reported to use the transcellular route (cellular 
invasion) [11, 14, 33]. Surprisingly, a correlation between 
meningeal cell adhesion and invasion by the strains stud-
ied was not observed, suggesting that different bacterial 
and/or host cell factors are probably involved in these 
interactions.
Of the different well-characterized S. suis serotype 2 
virulence factors, the CPS has, amongst its various prop-
erties, been described to modulate the adhesion to and 
invasion of epithelial and endothelial cells [27, 29, 30, 
34]. Meanwhile, the SLY has more recently been sug-
gested to be involved in the adhesion to and invasion of 
human epithelial cells at sub-cytolytic concentrations 
[35]. Finally, the roles of cell wall modifications, includ-
ing the D-alanylation of the LTA and N-acetylation of 
the PGN, in adhesion and invasion have been studied 
using pBMEC and porcine tracheal epithelial cells [8, 
28]. Given these properties, the role of these factors on 
the adhesion to and invasion of meningeal cells by S. suis 
was determined. The adhesion of S. suis to meningeal 
cells was significantly modulated by the CPS (p < 0.001) 
(Fig. 1C): the absence of the CPS increased adhesion by 
tenfold. Meanwhile, the SLY and cell wall modifications 
had no effect. The absence of the CPS also significantly 
increased invasion of meningeal cells (Fig.  1D), by one 
hundredfold (p < 0.001), such that the intracellular bac-
teria/cell ratio was of 10. These modulations by the CPS, 
though expected since it is known to mask various sur-
face proteins implicated in adhesion and invasion, are 
similar to those obtained using pBMEC and porcine 
tracheal epithelial cells [11, 28, 34]. In fact, P1/7 was 
non-invasive when encapsulated, but highly invasive 
in the absence of its CPS. Regulation of CPS expression 
may play an important role in bacterial-host interactions 
in  vivo [1]. On the other hand, the SLY did not modu-
late the adhesion to and invasion of pBMEC or porcine 
tracheal epithelial cells by S. suis, as was observed in the 
present study [11, 28]. Meanwhile, the D-alanylation 
of the LTA modulated the adhesion to and invasion of 
pBMEC, but not of porcine tracheal epithelial cells [8, 11, 
28]. Consequently, different receptors may be implicated 
in adhesion and invasion according to the cell type and/
or species.
Streptococcus suis serotype 2 adheres to and invades 
human astrocytes and these interactions are modulated 
by the CPS and, to a certain extent, by the SLY and cell wall 
modifications
In the case where S. suis serotype 2 would modulate its 
CPS, the pathogen may penetrate the meningeal cells 
of the pia mater, as observed in this study, in order to 
reach the astrocytes of the glia limitans superficialis 
[21]. As with meningeal cells, no significant differences 
were observed between adhesion of the different STs to 
astrocytes. Indeed, adhesion ranged between 1  ×  105 
and 5  ×  106 CFU, equivalent to 1 and 50 bacteria/cell, 
respectively (Fig. 2A). Moreover, the strains P1/7, LPH4 
and 1088563 adhered similarly, but significantly less than 
the other strains (p < 0.05). The adhesion levels of S. suis 
serotype 2 to human astrocytes are similar to those previ-
ously reported for GBS serotypes III and V [21].
Since all of the S. suis strains adhered to astrocytes, 
their subsequent invasion capacity was evaluated. Unlike 
with meningeal cells, multiple strains were, in theory, 
capable of biologically relevant invasion (Fig. 2B). Indeed, 
at least 1 × 105 CFU, equivalent to 1 intracellular bacte-
rium/cell, were recovered following infection with the 
different strains, with the exception of P1/7 and 89-1591. 
Differences were nonetheless observed between the 
strains capable of invasion: 31533 and 1088563 invaded 
the cells significantly more than did SC84, LPH4 or 
MNCM43 (p  <  0.01). These differences suggest that 
invasion of astrocytes by S. suis is a strain-specific char-
acteristic: as mentioned previously however, the char-
acteristics of ST25 and ST28 strains remain largely 
unknown. These results are different from those obtained 
using murine astrocytes, which did not internalize the S. 
suis serotype 2 strains 31533 (ST1) and SC84 (ST7), also 
used in this study [4]. On the contrary, invasion of human 
astrocytes by GBS was reported as infrequent since the 
intracellular bacterium/cell ratio recovered following 
infection was much lower than 1 [21]. As with meningeal 
cells however, S. suis adhesion to and invasion of astro-
cytes did not correlate.
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Since S. suis interacted with astrocytes, the role of the 
CPS, SLY and cell wall modifications were evaluated. 
Adhesion to human astrocytes was significantly modu-
lated by the CPS (p < 0.001) (Fig. 2C), its absence increas-
ing adhesion by tenfold. Meanwhile, the absence of the 
SLY and cell wall modifications did not modulate the 
adhesion of S. suis to astrocytes. The absence of the CPS 
also significantly increased the invasion capacity of astro-
cytes (p  <  0.001) (Fig.  2D), for which the intracellular 
bacteria/cell ratio recovered was of 5, equivalent to a ten-
fold increase. This greatly differs from murine astrocytes, 
which S. suis did not invade even in the absence of CPS [4]. 
Unlike with meningeal cells however, the absence of the 
SLY and D-alanylation of the LTA significantly decreased 
invasion of astrocytes by S. suis (p < 0.01): the strain was 
no longer capable of biologically relevant cell invasion. 
Meanwhile, as with meningeal cells, the N-acetylation of 
the PGN had no effect. These results are in accordance 
with previous studies: sub-cytolytic levels of SLY increased 
the invasion capacity of S. suis serotype 2 in epithelial cells 
[35], while, as mentioned above, the D-alanylation of the 
LTA modulated the invasion of pBMEC [8].
Fig. 2 Interactions of S. suis serotype 2 with human astrocytes. Bacterial adhesion (A) and invasion (B) of human astrocytes by the S. suis strains 
belonging to different sequence types (STs), and adhesion (C) and invasion (D) of human astrocytes by the mutant strains. Results are expressed 
as log10 mean ± SEM CFU obtained from three independent experiments. Dotted lines indicate a ratio of 1 intracellular bacterium/cell. The use of 
different letters (a, b or c) indicates a significant difference between groups (p < 0.01); **(p < 0.01); ***(p < 0.001)
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Streptococcus suis serotype 2 induces little inflammatory 
response from infected human meningeal cells
Streptococcus suis-induced inflammation is a charac-
teristic of the infection that can lead to an exacerbated 
inflammatory response and host death [36]. Furthermore, 
meningitis, the hallmark of the S. suis CNS infection, is 
defined as an inflammation of the meninges in which the 
surrounding CNS tissue may be implicated [36]. Conse-
quently, an understanding of the role of these cells in the 
production of inflammatory mediators following S. suis 
serotype 2 infection is crucial.
Human meningeal cells have been previously reported 
to produce the pro-inflammatory cytokine interleukin 
(IL)-6 and chemokines C–C motif ligand (CCL)2, CCL5 
and C–X–C motif ligand (CXCL)8 in response to menin-
geal pathogens, but not IL-1α, IL-1β, IL-10, IL-12, tumor 
necrosis factor (TNF)-α, CCL3 or CCL4 [21–23]. Conse-
quently, only the production of IL-6, CCL2, CCL5, and 
CXCL8 was quantified 24 h following infection with the 
different S. suis strains. Meningeal cells infected with 
N. meningitidis, used as a positive control, significantly 
produced all four mediators (p < 0.01). However, no pro-
duction of IL-6, CCL2 or CXCL8 was observed when 
cells were infected with S. suis, regardless of the strain 
(data not shown). Interestingly, a significant produc-
tion of CCL5 was induced, but by both ST1 strains only 
(p  <  0.01) (Fig.  3). The levels were significantly greater 
when cells were infected with 31533 than with P1/7 
(p  <  0.01). This production of CCL5 corroborates with 
previous results in which elevated levels of the mediator 
were observed in the CSF of human patients with bacte-
rial meningitis [37]. Furthermore, CCL5 is implicated 
in the chemoattraction of monocytes, which massively 
infiltrate the SAS and meninges during S. suis meningi-
tis [36]. An absence of these four inflammatory media-
tors was also observed when human meningeal cells were 
infected with GBS or S. pneumoniae [21, 23]. By contrast, 
these cells produced important levels of the four media-
tors following infection with N. meningitidis and H. influ-
enzae, but only produced CCL2 and CXCL8 following 
infection with E. coli [23]. However, S. suis serotype 2 
induced IL-6, CCL2 and CXCL8 from hBMEC and IL-6 
and CXCL8 from pBMEC, suggesting a possible cell and/
or species specificity [38, 39].
Given the relative absence of the inflammatory media-
tors evaluated, the S. suis-induced cytotoxicity was 
evaluated (Table 1). Cytotoxicity levels were below 10 % 
following infection with the different strains, suggest-
ing that unlike with the hBMEC and pBMEC, the SLY, 
produced by the ST1 and ST7 strains but not by the 
ST25 or ST28 strains, was not toxic for human menin-
geal cells. Consequently, the absence of the meningeal 
cell inflammatory mediators evaluated was probably 
not due to cell death. It is possible that human menin-
geal cells do not express certain of the various receptors 
implicated in the S. suis serotype 2 recognition, includ-
ing TLRs (TLR2, TLR4, TLR9, and possibly, TLR3) and 
NLRs (NOD2) [40]. Of these however, the TLR2, often 
considered as the most important to the S. suis serotype 
2 pathogenesis, and TLR4, are present on the cell sur-
face [1, 41].
Fig. 3 Only S. suis serotype 2 ST1 strains induce CCL5 from infected 
human meningeal cells. CCL5 production from human meningeal 
cells infected with the S. suis strains belonging to different sequence 
types (STs). Results are expressed as mean ± SEM ng/ml obtained 
from three independent experiments. The use of different letters (a, 
b or c) indicates a significant difference between groups (p < 0.01). 
**Indicates a significant difference between N. meningitidis and the 
medium (p < 0.01)
Table 1 Streptococcus suis serotype 2-induced human 











P1/7 1 Yes 0.1 ± 0.1 38.2 ± 3.4
31533 1 Yes 3.4 ± 1.2 63.3 ± 0.6
SC84 7 Yes 9.1 ± 2.6 35.3 ± 6.2
89‑1591 25 No 0.0 ± 0.0 71.5 ± 1.5
LPH4 25 No 6.1 ± 2.2 28.9 ± 6.0
1088563 28 No 0.0 ± 0.0 12.0 ± 3.9
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Streptococcus suis serotype 2 does not induce an 
inflammatory response from infected human astrocytes
Human astrocytes produce various inflammatory media-
tors following bacterial infection, including IL-6, CCL2, 
CCL5, and CXCL8 [21]. Consequently, these mediators 
were quantified following infection with the different 
S. suis strains. As with meningeal cells, N. meningitidis 
induced a significant production of all four mediators 
(p  <  0.01). Meanwhile, no production of IL-6, CCL2, 
CCL5 or CXCL8 was observed when cells were infected 
with S. suis, regardless of the strain (data not shown). 
Interestingly, these results vary from those obtained 
using murine astrocytes, which were an important 
source of TNF-α, IL-6, CCL2, and CXCL1 following S. 
suis serotype 2 infection [4]. Furthermore, recognition 
of S. suis serotype 2 by murine astrocytes was mainly 
TLR2-dependent, since the expression of TLR1, TLR4 
and TLR6 was barely modulated following infection [4]. 
Meanwhile S. suis serotype 2-induced TNF-α and CCL2 
were partially dependent on TLR2 in murine astrocytes 
[4]. By contrast, in the present study, no CCL2 produc-
tion was observed when human astrocytes were infected 
with S. suis serotype 2, while production of TNF-α was 
not determined. Consequently, the species from which 
the cells originate appears to play an important role on 
the results obtained, as the receptors present may vary, 
which could influence the subsequent inflammatory 
response [42, 43].
Given the absence of the inflammatory mediators 
measured, S. suis-induced astrocyte cytotoxicity was 
also evaluated (Table 1). In contrast to the lack of menin-
geal cell death following infection with S. suis, astro-
cytes were generally more sensitive to infection. The 
ST1, ST7 and ST25 strains induced important cytotox-
icity, which ranged between approximately 30 and 70 %, 
while the ST28 strains caused little cytotoxicity (less 
than 15 %). The SLY may be partially responsible for the 
S. suis-induced astrocyte cell death since the ST1 and 
ST7 strains induced higher cytotoxicity levels than did 
the SLY-negative strain LPH4. Furthermore, the differ-
ences observed between the ST1 and ST25 strains sug-
gest that strain-specific factors are implicated in these 
interactions. Nevertheless, the S. suis-induced astrocyte 
cell death was probably not responsible for the absence 
of the inflammatory mediators evaluated, since N. men-
ingitis caused near total cell death, with 90 % cytotoxic-
ity, yet induced important levels of these inflammatory 
mediators.
Conclusions
Streptococcus suis serotype 2 interacted with human 
meningeal cells and astrocytes via the adhesion to both 
cell types; invasion of meningeal cells was rare however, 
whereas that of astrocytes was generally more frequent. 
Furthermore, these interactions were largely modulated 
by the CPS, and to a certain extent, by the SLY and cell 
wall modifications. Regardless of the fact that S. suis 
interacted with meningeal cells and astrocytes, little or 
no production of the inflammatory mediators evaluated 
was observed. This suggests that the meningeal cells of 
the leptomeninges and the astrocytes of the underly-
ing glia limitans superficialis may not be directly impli-
cated in the inflammatory response observed during 
S. suis meningitis in humans. Nevertheless, the use of 
a microarray or proteomic assay investigating a larger 
number and greater variety of inflammatory mediators 
induced by S. suis serotype 2 in these cell types may yield 
further details. Alongside, a given ST could not be cor-
related with a specific interaction since important varia-
tions were observed between strains within a single ST. 
Consequently, the interactions with meningeal cells and 
astrocytes, though important for the pathogenesis, are 
not ST-dependent but rather a characteristic of S. suis 
serotype 2 that varies according to the strain.
Methods
Bacterial strains and growth conditions
The well-encapsulated S. suis serotype 2 strains and iso-
genic mutants for different well-characterized virulence 
factors used in this study are listed in Table  2. Bacteria 
were grown overnight on Columbia Blood Agar contain-
ing 5 % sheep blood (v/v) at 37 °C with 5 % CO2 (Oxoid, 
Basingstoke, UK). Five  ml of Todd-Hewitt Broth (THB; 
Becton–Dickinson, Swindon, UK) were inoculated and 
incubated for 8 h at 37 °C with 5 % CO2. Working cultures 
were prepared by inoculating 30 ml of THB with 10 µl of 
a 10−3 dilution of the 8 h cultures, incubated for 16 h at 
37 °C with 5 % CO2. Bacteria were washed twice with pH 
7.3 phosphate-buffered saline (PBS), resuspended in cell 
culture medium, appropriately diluted, and plated on 
Todd-Hewitt Broth agar (THA) to accurately determine 
concentrations. The N. meningitidis serogroup B strain 
MC58 [44], used as a positive control, was grown on sup-
plemented GC agar and bacterial suspensions prepared 
in cell culture medium, as previously described [24].
Human meningeal cell and astrocyte cultures
Human meningioma cells, obtained from surgically 
removed tumors as previously described, express the 
characteristic markers of desmosomal desmoplakin, 
epithelial membrane antigen, vimentin, and cytokera-
tin [24]. The cells were grown in Dulbecco’s Modified 
Eagle Medium containing Glutamax-1 and sodium pyru-
vate (Lonza, Slough, UK) supplemented with 10  % fetal 
calf serum (v/v) (FCS; Lonza) and seeded in flasks pre-
coated with 5  mg/cm2 of type I collagen from rat tail 
Page 8 of 10Auger et al. BMC Res Notes  (2015) 8:607 
(Becton–Dickinson); culture passages 2–10 were used 
[24]. SVGmm human fetal astrocyte cells were grown in 
Eagle’s Minimal Essential Medium (Lonza) supplemented 
with 10 % FCS (v/v) [45].
Infection of human meningeal cells and astrocytes
Human meningeal cells and astrocytes were grown 
to confluence in 24-well cell culture plates, averaging 
4  ×  104 cells/well and 1  ×  105 cells/well, respectively. 
Cell monolayers were maintained overnight in medium 
containing 1  % FCS (v/v) and washed twice with warm 
PBS prior to bacterial challenge, in triplicate, with the 
different S. suis serotype 2 wild-type or mutant strains, 
or N. meningitidis. Based on preliminary assays, 1 ml of 
4 × 104 CFU/well for meningeal cells and 1 × 105 CFU/
well for astrocytes [multiplicity of infection (MOI) = 1] 
was added for bacterial adhesion. For bacterial inva-
sion, host cell cytotoxicity and inflammatory activation, 
4 × 106 CFU/well for meningeal cells and 1 × 107 CFU/
well for astrocytes (MOI = 100) were added. Monolayers 
were incubated for 9  h (adhesion and invasion) or 24  h 
(cell cytotoxicity and inflammatory activation) at 37  °C 
with 5 % CO2 as previously described [21–23].
Bacterial adhesion and invasion measurement
After incubation, cells were washed four times with 
warm PBS, lysed using 250 µl/well of 1 % saponin (w/v) 
(Sigma-Aldrich, Dorset, UK) in PBS and incubated for 
15  min at 37  °C with 5  % CO2. Bacterial adhesion was 
measured by plating the lysates onto THA and incubat-
ing overnight at 37  °C with 5 % CO2. Bacterial invasion 
was carried out using the antibiotic protection assay [5]: 
cell medium was removed after 9  h, monolayers were 
washed twice with warm PBS and 1 ml of medium con-
taining 5 µg/ml penicillin G (Sigma-Aldrich) and 100 µg/
ml of gentamicin (Sigma-Aldrich) was added for 90 min 
at 37  °C with 5 % CO2 to kill extracellular bacteria. The 
last wash was plated to confirm antibiotic activity.
Host cell cytotoxicity assay
Lactate dehydrogenase (LDH) release was measured 
24  h post-infection using the CytoTox 96 Non-Radioac-
tive Cytotoxicity Assay kit (Promega, UK) according to 
instructions. Non-infected monolayers were included 
for measurement of spontaneous LDH release and maxi-
mum LDH release was induced using the lysis reagent 
included in the kit. The absorbance was read at 492 nm 
using the iMark Absorbance Reader (Bio-Rad, Hercules, 
CA, USA).
Host cell inflammatory activation
The measurement of the pro-inflammatory cytokine IL-6 
and chemokines CCL2, CCL5 and CXCL8 was carried 
out by enzyme-linked immunosorbent assay as previ-
ously described [22].
Statistical analyses
Unpaired t-tests, Mann–Whitney rank sum tests and 
one-way ANOVA, where appropriate, were performed to 
find statistical differences between groups. p < 0.05 was 
considered statistically significant.
Abbreviations
CCL: C–C motif ligand; CFU: colony forming unit; CNS: central nervous 
system; CPEC: choroid plexus epithelial cells; CPS: capsular polysaccharide; 
CSF: cerebrospinal fluid; CXCL: C–X–C motif ligand; FCS: fetal calf serum; GBS: 
group B Streptococcus; hBMEC: human brain microvascular endothelial cells; 
IL: interleukin; LDH: lactate dehydrogenase; LTA: lipoteichoic acid; MOI: mul‑
tiplicity of infection; NOD: nucleotide‑binding oligomerization domain; NLR: 
NOD‑like receptors; pBMEC: porcine brain microvascular endothelial cells; PBS: 
phosphate‑buffered saline; PGN: peptidoglycan; SAS: subarachnoid space; SLY: 
suilysin; ST: sequence type; THA: Todd‑Hewitt Broth agar; THB: Todd‑Hewitt 
Broth; TLR: toll‑like receptor; TNF: tumor necrosis factor; v/v: volume/volume; 
w/v: weight/volume.
Table 2 Streptococcus suis serotype 2 strains used in this study
Strain Sequence type Country Host Phenotype References
P1/7 1 United Kingdom Pig Wild‑type [46]
P1/7ΔcpsF 1 – – Non‑encapsulated mutant [6]
31533 1 France Pig Wild‑type [47]
31533Δsly 1 – – Suilysin‑deficient mutant [7]
31533ΔdltA 1 – – D‑alanylation of lipoteichoic acid‑deficient mutant [8]
31533ΔpgdA 1 – – N‑deacetylation of peptidoglycan‑deficient mutant [9]
SC84 7 China Human Wild‑type [48]
89‑1591 25 Canada Pig Wild‑type [49]
LPH4 25 Thailand Human Wild‑type [50]
1088563 28 Canada Pig Wild‑type [51]
MNCM43 28 Thailand Human Wild‑type [50]
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